Diabetes and Cardiovascular Disease: Etiology, Treatment, and Outcomes Book

	Epidemiology and Genetic Determinants of Diabetes Mellitus
1	Type 2 Diabetes in Youth: A New Epidemic	1
2	Undiagnosed Diabetes: Burden and Significance in the Canadian Population	7
3	Genes, Environment and Diabetes in Canadian Aboriginal Communities	11
4	Diabetes in Sub-Saharan Africa	21
5	Coronary Heart Disease and Risk Factors in Asian Indians	27
	Metabolic Risk Factors in Diabetes and Cardiovascular Disease
6	The Plasma Glucose Level - A Continuous Risk Factor for Vascular Disease in Both Diabetic and Non-Diabetic People	35
7	Modified Lipoproteins and Cardiovascular Risk	41
8	Advances in Lipid-Lowering Therapy in Atherosclerosis	49
9	Homocysteine as a Risk Factor in Cardiovascular Disease	59
10	Endothelial Integrity and Repair	65
11	Molecular Mechanisms of Endothelial Dysfunction in the Diabetic Heart	75
12	A Study of Vascular Wound Healing in a Rabbit Model of Type I Diabetes	87
13	Endothelins in the Microvasculature and Heart in Diabetes	97
14	Diabetes and Endothelial Function: Implications for Coronary Angioplasty	109
	Hypertension and Diabetes Mellitus
15	The Effect of Hypertension in Diabetes	115
16	The Diabetic Hypertensive (or Hypertensive Diabetic) - A Compelling Need to Optimize Blood Pressure	119
17	Left Ventricular Diastolic Dysfunction in Diabetic or Hypertensive Subjects: Role of Collagen Alterations	127
18	Alterations in the Vascular Actions of Insulin in the Pathogenesis of Insulin Resistance and Hypertension	133
19	Cardiac Hypertrophy in Diabetes Patients with the without Hypertension: Effects of Troglitazone, a Novel Antidiabetic Drug, on Diastolic Function	143
20	Cost and Benefits of Blood Pressure Monitoring and Control	149
	Cardiac Lipid Metabolism in Diabetes
21	Malonyl COA Control of Fatty Acid Oxidation in the Diabetic Rat Heart	155
22	Alterations in 1,2-Diacylglycerol and Ceramides in Diabetic Rat Heart	167
23	Regulation of Myocardial Phospholipid N-Methylation by Insulin and Diabetes	175
24	Reduction of Phosphatidylinositol-4,5-Bisphosphate Mass in Heart Sarcolemma during Diabetic Cardiomyopathy	183
25	Tumor Necrosis Factor-[alpha], Sphingomyelinase and Ceramides Activate Tyrosine Kinase, p21Ras and Phosphatidylinositol 3-Kinase: Implications for Glucose Transport and Insulin Resistance	191
	Cardiac Function and Oxidative Stress in Diabetes
26	Antioxidants, Free Radical Stress and Diabetes	201
27	Oxidative Stress and Functional Deficit in Diabetic Cardiomyopathy	213
28	Ketosis and the Generation of Oxygen Radicals in Diabetes Mellitus	221
29	Effect of Diabetes Mellitus on Hemodynamic and Cardiometabolic Correlates in Experimental Myocardial Infarction	229
30	Cardiac Function in Perfused Hearts from Diabetic Mice	241
31	Mg[superscript 2+]-Dependent Atpase Activity in Cardiac Myofibrils from the Insulin-Resistant Jcr:La-Cp Rat	247
32	Cyclic Nucleotide Phosphodiesterase Families in Intracellular Signaling and Diabetes	253
33	Alterations in G-Protein-Linked Signal Transduction in Cardiovascular Vascular Smooth Muscle in Diabetes	263
	Glycemic Control and Improved Cardiovascular Function
34	Mechanism of HDL Lowering in Insulin Resistant States	273
35	Insulin Treatment Post Myocardial Infarction: The Digami Study	279
36	Response to Ischemia and Endogenous Myocardial Protection in the Diabetic Heart	285
37	Type 2 Diabetes: Pharmacological Intervention in an Animal Model	295
38	The Diabetic Heart and Cardiac Glycosides	303
39	Hyperglycemia-Induced Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells: Implications in the Pathogenesis of Vascular Dysfunction in Diabetes	311
40	Regulation of Myocardial and Skeletal Muscle NA,K-ATPase in Diabetes Mellitus in Humans and Animals	319
	Diabetes Management - A Multidisciplinary Approach
41	Food Strategies for Diabetes and Heart Health	323
42	The Atherosclerosis Reversal Clinic: The Way of the Future	331
43	Lipid Clinics/Cardiovascular Risk Reduction Clinics: Current State and Future Considerations	337
44	Amputation Prevention and Rehabilitation in Diabetes	349
45	Laboratory Testing in Diabetes Mellitus	359
	Health Promotion in Preventing Diabetes and its Complications
46	Diabetes and Cardiovascular Disease	367
47	Prevalence of Cardiovascular Risk Factors in Canadians with Diabetes Mellitus	373
48	G7 Project Promoting Heart Health	381
49	Canadian Heart Health Initiative: Research Review	385
	Health Policy and National Strategies in Diabetes
50	Putting Policy into Action	389
51	National and International Strategies to Prevent Obesity and Diabetes	393
52	The Diabetes Council of Canada (DCC): Coordinating National Diabetes Strategies	401
53	The Federal Government and Diabetes: An Incremental Process	405